Related Experiment Videos
Results from the Endologix PowerLink multicenter trial
Christopher J Hansen1, Ihab Aziz, Benjamin B Kim
1Division of Vascular Surgery, Harbor-UCLA Medical Center, 1000 West Carson Street, Torrance, CA 90509, USA.
Seminars in Vascular Surgery
|August 16, 2003
Summary
The Endologix PowerLink system effectively treats abdominal aortic aneurysms (AAA). This endoluminal graft shows high success, low complications, and durability in a multicenter trial.
Area of Science:
- Vascular Surgery
- Medical Devices
- Endovascular Techniques
Background:
- Abdominal aortic aneurysms (AAA) pose significant health risks.
- Endoluminal grafts offer a less invasive treatment option for AAA.
- The Endologix PowerLink system is a novel one-piece, bifurcated graft design.
Purpose of the Study:
- To evaluate the safety and efficacy of the Endologix PowerLink system for AAA treatment.
- To assess the technical success, clinical outcomes, and device performance.
- To compare the results with existing endoluminal graft technologies.
Main Methods:
- A multicenter clinical trial was conducted.
- The Endologix PowerLink system was implanted in patients with AAA.
- Outcomes were assessed through technical success rates, complication rates, aneurysm size changes, and follow-up for endoleak, migration, and rupture.
Main Results:
- High technical success rate achieved.
- Low rates of morbidity and mortality observed.
- Significant mean decrease in AAA size over time.
- Low endoleak and migration rates at 16-month mean follow-up.
- No device-related ruptures reported.
Conclusions:
- The Endologix PowerLink system demonstrates favorable safety and efficacy in AAA treatment.
- The device offers a durable and effective endovascular solution.
- Results compare favorably to other published endoluminal graft outcomes.